1. Boston type 1 keratoprosthesis for failed keratoplasty
- Author
-
Michael D. Wagoner, Jonathan L. Hager, Alex W. Cohen, David L. Phillips, Mark A. Greiner, Anna S. Kitzmann, Kenneth M. Goins, and Jeffrey D. Welder
- Subjects
Adult ,Male ,medicine.medical_specialty ,Keratoconus ,genetic structures ,Prosthesis Retention ,Keratoprosthesis ,medicine.medical_treatment ,Visual Acuity ,Prosthesis ,Corneal Diseases ,Corneal Transplantation ,Prosthesis Implantation ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Endophthalmitis ,Corneal edema ,Ophthalmology ,medicine ,Humans ,Fungal keratitis ,Treatment Failure ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Wound dehiscence ,Retinal Detachment ,Prostheses and Implants ,Middle Aged ,medicine.disease ,eye diseases ,Surgery ,030221 ophthalmology & optometry ,Female ,Artificial Organs ,sense organs ,business ,030217 neurology & neurosurgery ,Follow-Up Studies - Abstract
The purpose of this study was to evaluate the outcomes of the Boston type 1 keratoprosthesis (Kpro-1) in eyes with failed keratoplasty. A retrospective review was performed of every patient treated with a Kpro-1 at a tertiary eye care center between January 1, 2008 and July 1, 2013. Eyes with a failed keratoplasty originally performed for corneal edema, trauma, or keratoconus were included in the statistical analysis. The main outcome measures were visual outcome, prosthesis retention, and postoperative complications. Twenty-four eyes met the inclusion criteria, including 13 eyes with corneal edema, 8 eyes with trauma, and 3 eyes with keratoconus. After a mean follow-up period of 28.9 months (range 7-63 months), the median best corrected visual acuity (BCVA) was 20/125. The BCVA was ≥ 20/40 in 4 (16.7 %) eyes, ≥ 20/70 in 9 (37.5 %) eyes, and ≥ 20/200 in 14 (58.3 %) eyes. Overall, the postoperative BCVA improved in 17 (70.9 %) eyes, was unchanged in 3 (12.5 %) eyes, and was worse in 4 (16.7 %) eyes. The initial Kpro-1 was retained in 22 (91.7 %) eyes, and was successfully repeated in the other 2 eyes. One or more serious prosthesis- or sight-threatening complications occurred in 8 (33.3 %) eyes. These included 1 case of wound dehiscence leading to prosthesis extrusion, 1 case of fungal keratitis leading to prosthesis extrusion, 4 cases of endophthalmitis, and 5 retinal detachments. The Boston Kpro-1 is associated with an excellent prognosis for prosthesis retention and satisfactory visual improvement in eyes with previous failed keratoplasty.
- Published
- 2015
- Full Text
- View/download PDF